☰
Scientist-C
Our research thrusts
is to engineering delivery systems for poorly water soluble drugs towards
therapeutic clinical applications primarily, against neglected infectious
diseases (Visceral Leishmaniasis). We focus on the development of nanomedicines
based on biological nanomaterials with considerable priority on interface
between in vitro and in vivo studies and how logically-designed
and engineered drug delivery systems can be translated into
clinically-effective therapeutics.
empty! record not found
Email: vivek.ra202127@inst.ac.in
Reg. No.: RA-01-202127
Email: kanika.ph21215@inst.ac.in
Reg. No.: PH21215
Email: aaqib.ph20211@inst.ac.in
Reg. No.: PH20211
Email: shabi.ph15219@inst.ac.in
Reg. No.: PH15219
Email: archana.ph19205@inst.ac.in
Reg. No.: PH19205
Email: aakriti.ph17203@inst.ac.in
Reg. No.: PH17203
empty! record not found
Transport mechanism of hydroxy-propyl-beta-cyclodextrin modified solid lipid nanoparticles across human epithelial cells for the oral absorption of antileishmanial drugs: Shabi Parvez, Archana Karole, Shyam Lal Mudavath*, (2022) Biochimica et Biophysica Acta (BBA) - General Subjects, 130157: . DOI: https://doi.org/10.1016/j.bbagen.2022.130157
Fabrication, Physicochemical characterization and In vitro anticancer activity of Nerolidol encapsulated Solid Lipid Nanoparticles in Human Colorectal Cell Line: Shabi Parvez, Archana Karole,Shyam Lal Mudavath*, (2022) Colloids and Surfaces B: Biointerfaces, Accepted: . DOI: https://doi.org/10.1016/j.colsurfb.2022.112520
Effervescent based nano-gas carrier enhanced the bioavailability of poorly aqueous soluble drug: A comprehensive mechanistic understanding : Archana Karole, Shabi Parvez, Richa Singh Thakur, Shyam Lal Mudavath*, (2022) Journal of Drug Delivery Science and Technology, . DOI: https://doi.org/10.1016/j.jddst.2022.103167
Carboxymethyl chitosan modified lipid nanoformulations as a highly efficacious and biocompatible oral anti-leishmanial drug carrier system: Aakriti Singh, Ganesh Yadagiri , Manorma Negi, Anurag Kumar Kushwaha, Om Prakash Singh, Shyam Sundar, and Shyam Lal Mudavath*, (2022) International Journal of Biological Macromolecules, 204: 373-385. DOI: https://doi.org/10.1016/j.ijbiomac.2022.02.006
Coalition of biological agent (melatonin) with chemotherapeutic agent (amphotericin B) for combating visceral leishmaniasis via oral administration of modified solid lipid nanoparticles: Parvez S, Yadagiri G,Arora K, Javaid A,Kushwaha A.K.,Singh O.P.,Sundar S,Mudavath S.L*., (2021) ACS Biomaterials Science & Engineering, . DOI: https://doi.org/10.1021/acsbiomaterials.1c00859
Downshifting and upconversion dual mode emission from lanthanide doped GdPO4 nanorods for unclonable anti-counterfeiting: Pushpendra, I. Suryawanshi, S. Srinidhi, S. Singh, R. Kalia, R. K. Kunchala, S.L. Mudavath, B.S. Naidu*, (2021) Mater. Today Commun., 26: 102144. DOI: 10.1016/j.mtcomm.2021.102144
Detection of Latent Fingerprints using Luminescent Gd0.95Eu0.05PO4 Nanorods: Pushpendra, I. Suryawanshi, R. Kalia, R. K. Kunchala, S.L. Mudavath, B.S. Naidu*, (2021) J. Rare Earths, 40: 572-578. DOI: 10.1016/j.jre.2021.01.015
Nanodiagnostics in Leishmaniasis: A New Frontier for Early Elimination: Mallikarjuna Rao Gedda, Prasoon Madhukar, Ashish Shukla, Shyam Lal Mudavath, Onkar Nath Srivastava, Om Prakash Singh and Shyam Sundar, (2020) WIREs Nanomedicine and Nanobiotechnology, Accepted: 1-22. DOI: 10.1002/wnan.1675
Recuperating the biopharmaceutical aspects of amphotericin B and paromomycin using a chitosan functionalized nanocarrier via oral route for enhanced anti-leishmanial activity: Shabi Parvez, Ganesh Yadagiri, Archana Karole, Om Prakash Singh, Anurag Verma, Shyam Sundar and Shyam Lal Mudavath*, (2020) Front. Cell. Infect. Microbiol., . DOI: 10.3389/fcimb.2020.570573
Formulation, characterization, and in vitro anti-leishmanial evaluation of amphotericin b loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate: Aakriti Singh‡, Ganesh Yadagiri‡, Shabi Parvez, Om Prakash Singh, Anurag Verma, Shyam Sundar, Shyam Lal Mudavath*, (2020) Materials Science & Engineering C, 117: 111279. DOI: 10.1016/j.msec.2020.111279
Evaluation of Safety and Antileishmanial efficacy of Amine Functionalized Carbon-based Composite Nanoparticle appended with Amphotericin B: An In vitro and Preclinical Study: Mallikarjuna Rao Gedda,Prasoon Madhukar,Alok Kumar Vishwakarm,Vimal Verma,Anurag Kumar Kushwaha,Ganesh Yadagiri,Shyam Lal Mudavath,Om Prakash Singh,Onkar Nath Srivastava,Shyam Sundar, (2020) Front. Chem., . DOI: https://doi.org/10.3389/fchem.2020.00510
Improvising anti-leishmanial activity of Amphotericin B and Paromomycin using co-delivery in D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) tailored Nano-lipid carrier system: Shabi Parvez, Ganesh Yadagiri, Aakriti Singh, Archana Karole, Om Prakash Singh, Shyam Sundar,Shyam Lal Mudavath*, (2020) Chemistry and Physics of Lipids, 231: 104946. DOI: 10.1016/j.chemphyslip.2020.104946
Sensible graphene oxide differentiates macrophages and Leishmania: A Bio-nano interplay in attenuating intracellular parasite: Aakriti Singh‡, Sandeep Sharma‡, Ganesh Yadagiri, Shabi Parvez, Nikhil Koratkar, Om Prakash Singh, Shyam Sundar, Vijayakumar Shanmugam* and Shyam Lal Mudavath*, (2020) RSC Advances, 10: 27502–27511. DOI: DOI: 10.1039/d0ra04266h
Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: An effective oral combination against experimental murine visceral leishmaniasis: Shabi Parvez‡, Ganesh Yadagiri‡, Mallikarjuna Rao Gedda, Aakriti Singh, Om Prakash Singh, Anurag Verma, Shyam Sundar, Shyam Lal Mudavath*, (2020) Scientific Reports, 10: 12243. DOI: https://doi.org/10.1038/s41598-020-69276-5
Enkephalins as a therapeutic intervention for visceral leishmaniasis: Ganesh Yadagiri,Shyam Lal Mudavath*, (2020) Medical Hypotheses, 144: 109956. DOI: doi.org/10.1016/j.mehy.2020.109956
Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application: Om Prakash Singh, Mallikarjuna Rao Gedda, Shyam Lal Mudavath, Onkar Nath Srivastava, Shyam Sundar, (2019) Nanomedicine, 14: 1911-1927. DOI: 10.2217/nnm-2018-0448
Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani: Chaubey P, Mishra B, Patel RR, Chaurasia S, Sundar S, Suvarna V, Monteiro M, (2018) Int J Biol Macromol, 111: 109-120. DOI: 10.1016/j.ijbiomac.2017.12.143
Galactosylated Chitosan for Enhanced and Efficient Antimicrobial and Antileishmanial Activities: A Novel Approach: Vishwakarma N.K.; Patel V.K.; Gundampati R.K.; Mudavath S.L.; Gupta T.; Ramesh K.; Jana K.K.; Dutta P.K.; Maiti P.; Mishra N.; Jagannadham M.V.; Sundar S.; Ray B., (2015) Asian Chitin J, 11: 11-18. DOI: NA
Characterization and evaluation of amine modified graphene Amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies: Talat M, Rai M, Srivastava ON, Sundar S, (2014) Drug Design, Development and Therapy, 8: 1235-47. DOI: 10.2147/DDDT.S63994
In vivo assessment of antileishmanial property of 4-(4, 4, 8-Trimethyl 7-oxo-3-oxabicyclo [3.3.1] non-2-yl)-benzoic acid methyl ester, an oxabicyclo [3.3.1] nonanones, in hamster model: Prakash Saudagar, Pipas Saha, Anil K. Saikia,Vikash Kumar Dubey,Shyam Sundar, (2014) Letters in Drug Design & Discovery, 11: 937-939. DOI: 10.2174/1570180811666140423203826
Comparative Evaluation of Blood and Serum Samples in Rapid Immunochromatographic Tests for Visceral Leishmaniasis: Kumar D, Khanal B, Tiwary P, Tiwary NK, Singh R, Koirala K, Boelaert M, Rijal S, Sundar S., (2013) J Clin Microbiol., 51(12): 3955-9.. DOI: 10.1128/JCM.01232-13
Oxabicyclo derivatives as novel antileishmanial compounds: Prakash Saudagar, Vikash Kumar Dubey, Anil Kumar Saikia, Pipas Saha, Shyam Lal Mudavath and Shyam Sundar, (2013) 863/KOL/2013 (Indian Patent), NA: NA. DOI: NA
Bioimmunotherapy with Recombinant Mouse Granulocyte-Macrophage Colony-Stimulating Factor (Rm GM-CSF) and Melatonin against Experimental Visceral Leishmaniasis: Ganesh Yadagiri, Om Prakash Singh, Shyam Sundar,Shyam Lal Mudavath*, (2020) SSRN, . DOI: https://ssrn.com/abstract=3534231
An oral formulation of Amphotericin B for the treatment of visceral Leishmaniasis: f-Gr-AmB: M Talat, M Rai, ON Srivastava, S Sundar, (2016) International Journal Of Infectious Diseases, 45: 3067. DOI: 10.1016/j.ijid.2016.02.790
Amine modified graphene mediated drug delivery of Amphotericin B for the treatment of visceral leishmaniasis: M. Rai, M. Talat, O.N. Srivastava, S. Sundar, (2014) International Journal of Infectious Diseases, 21S: 1–460. DOI: 10.1016/j.ijid.2014.03.753
Department of Medicine, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India
Department of Biochemistry, School of Life Sciences, University of Hyderabad, Gachibowli, Andhra Pradesh, India
Osmania University, Hyderabad, Andhra Pradesh, India
Scientist C:Institute of Nano Science and Technology, Habitat Centre, Phase- 10, Sector- 64, Mohali - 160062, Punjab, India (January 2019 to Present till date )
Scientist B:Institute of Nano Science and Technology, Habitat Centre, Phase- 10, Sector- 64, Mohali - 160062, Punjab, India (February 2015 to December 2018 )
Awarded Early Career Research Award by SERB, DST, GOI.
Awarded Bill Melinda Gates-ICID Travel Grant for presenting work at ICID March 2-5, 2016, Hyderabad, India.
Awarded International Travel Award from ICMR for presenting work at International Congress & Exhibition on Nanobiotechnology organized by Centre of Nanotechnology from June 2- 4th 2014 in Munster, Germany.
Awarded Rajiv Gandhi National Fellowship 2011-12 by University Grants Commission, New Delhi, India for pursuing Ph.D.
© Copyright Institute of Nano Science and Technology 2014 - 2022 All Rights Reserved With Institute of Nano Science and Technology
Website Design and Developed by SoftAdroit System Solutions